Bert’s February Watch List

I’m getting an itch to invest.  Even after purchasing Pfizer a few weeks ago I still have some capital that I am trying to deploy.  This is eerily starting to remind me of when Lanny ran into the same problem (at the same time as a matter of fact!) of having capital to deploy but  no where to put it.    Despite the fact that the market wasn’t cooperating this week, I have my eyes on a few stocks that are getting very close to my “buy” zone.   If the prices fall next week, I may not be able to resist buying.  Time to check out my February Watch List!

Watch List

Continue reading

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Recent Buy – Pfizer (PFE)

I couldn’t sit on the sidelines too long.  After a strong month of purchased in January, which saw me add to my current stakes in  ADM and CZNC,  I wanted to keep the momentum rolling.  At the end of my January dividend income article, I mentioned that I purchased a stock but haven’t disclosed the purchase yet to the community.  Well, that is about to change.  Last week I unloaded some capital and purchased a stake in Pfizer (PFE).  Let’s see why!

pfizer

 

Continue reading

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Bert’s 2016 Goals

I can’t write this without smiling.  2016 is going to be an amazing, life-changing year for me and I cannot wait until the ball drops on New Year’s Eve to make it official.  I’ll be marrying the love of my life at the end of May, so I don’t think there is a bad thing that can happen to me.   Well, now I left myself with an impossible task.  How on earth to I segue from that to discussing my 2015 investing goals?  Nothing I do this year will mean more to mean than that.  So I guess I will technically knock out one goal at the end of May?  Anyway…. now I’ll get down to business.  This article will discuss my 2016 goals!goals

Continue reading

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Top 5 Dividend Aristocrats with Low Debt to Equity Ratios

Recently, we saw the ugly side of debt.  As we all watched Kinder Morgan’s stock fall and wait for the final, inevitable sword of a dividend increase, there was one thing that became evident…KMI’s debt level was too high and the results were unsustainable in the current market environment (See Lanny’s awesome write up/analysis about KMI from earlier in the week).  The pressures mounted and management plus the Board of Directors decided to slash their dividend to preserve cash flow for capital expenditures and cover interest/dividend payments.   While debt isn’t a bad thing, I don’t want you leaving this intro thinking that’s my conclusion, runaway/uncontrolled debt can present many problems.  The name of our game on this website is investing in stocks with a growing dividend income stream, so we try to avoid companies and stocks that take us off of this course.  Which is very ironic considering that Lanny and I purchased shares in KMI just under a month ago (here and here) With the wound from KMI still fresh, I wanted to run a stock screener and identify several Dividend Aristocrats with low debt levels.  Check out our newest installment of our Top 5 list series (foundation stocks and low dividend yield/high dividend growth rate stocks)….the Top 5 Dividend Aristocrats with Low Debt to Equity Levels.

images

Continue reading

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Expected Dividend Increases in December

2015 is quickly approaching!  Holy smokes.  As the calendar turns for the final time this year, it is time to review which Dividend Aristocrats are expected to announce dividend increases in December.  For all new readers, we have reviewed projected dividend increases at the beginning of each month.  Why? Because the Dividend Diplomats love dividend increases, especially from Aristocrats.  With that being said, let’s review our projections from November and take a look ahead to the final month of 2014!

dividend increases in December

Continue reading

Facebooktwittergoogle_plusredditpinterestlinkedinmail